Found 8 matching trials
Tolerability of Utidelone Capsule in Patients With Advanced Solid Tumors PHASE1 The purpose of this trial is to evaluate the safety and tolerability of Uti...
Show More Location
University of Southern California
Learn More & Join Trial
Phase II Study of Utidelone Plus Fruquintinib Combination Therapy for Platinum-Resistant Recurrent Ovarian Cancer PHASE2 This study is a Prospective, Single-arm, Phase 2 clinical trial. The purpos...
Show More Location
Fudan University Shanghai Cancer Cente
Learn More & Join Trial
Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors PHASE2 This trial is an open, multicenter, phase II clinical trial to evaluate the...
Show More Location
Multiple Locations
Learn More & Join Trial
Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer PHASE2 This study aims to investigate the efficacy and safety of utidelone capsule...
Show More Location
Henan Cancer hospital
Learn More & Join Trial
Efficacy and Safety of Utidelone Capsule and Utidelone Injection in Patients With HER-2 Negative Advanced Breast Cancer PHASE3 This study is a randomized controlled study.The primary objective is to eva...
Show More Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
Phase I-II Clinical Trial of Utidelone Capsule in Patients With Advanced Solid Tumors PHASE1 This study has three parts. Part 1 is a dose-escalation trial, Part 2 is a ...
Show More Status
Active Not Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
Phase II Clinical Study of Utidelone Capsule (UTD2) in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PHASE2 This is an open, multicenter, phase II clinical study enrolling patients wi...
Show More Location
Multiple Locations
Learn More & Join Trial
Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma PHASE2 This is a multi-national, open-label, randomized, seamless phase II/III cli...
Show More Location
Bioresearch Partner
Learn More & Join Trial